U.S. Markets close in 4 hrs 25 mins

LENSAR, Inc. (LNSR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
8.00-0.10 (-1.23%)
As of 9:41AM EDT. Market open.

LENSAR, Inc.

2800 Discovery Drive
Orlando, FL 32826
United States
888 536 7271
http://www.lensar.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees100

Key Executives

NameTitlePayExercisedYear Born
Mr. Nicholas T. CurtisCEO & Director748.46kN/A1956
Mr. Thomas R. Staab IIChief Financial Officer347.26kN/A1968
Mr. Alan B. ConnaughtonChief Operating Officer519.52kN/A1972
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company was incorporated in 2004 and is headquartered in Orlando, Florida.

Corporate Governance

LENSAR, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.